Organophosphate (OP) chemicals include nerve agents and pesticides, and there is a growing concern of OP based chemical attacks against civilians. Current antidotes are essential in limiting immediate mortality associated with OP exposure. However, further research is needed to identify molecular mechanisms underlying long-term neurological deficits following survival of OP toxicity in order to develop effective therapeutics. We have developed rat survival models of OP induced status epilepticus (SE) that mimic chronic mortality and morbidity following OP intoxication. We have observed significant elevations in hippocampal calcium levels after OP SE that persisted for weeks following initial survival. Drugs inhibiting intracellular calcium-induced calcium release such as dantrolene, levetiracetam, and carisbamate lowered OP-SE mediated protracted calcium elevations. Given the critical role of calcium signaling in modulating behavior and cell-death mechanisms, drugs targeted at preventing the development of the calcium plateau could enhance neuroprotection, help reduce morbidity and improve outcome following survival of OP SE.
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Introduction The Increasing Risk for Organophosphate Exposure
Organophosphate (OP) chemicals include nerve agents such as Sarin and pesticides such as Parathion. These compounds are considered extremely lethal. The civilian population has been exposed to nerve agents under acts of war and terrorism. Recent examples include the reported 2015 Sarin gas attack in Ghouta, Syria . OP based pesticides have also been used against civilians during the Rhodesian War 4 and the accidental poisoning in Indian children following consumption of pesticide contaminated lunches 5 . In addition, civilians are exposed to OP's intentionally by suicide attempts or occupationally or due to industrial accidents. In fact, pesticide ingestion is one of the most common method for committing suicide in developing nations 6, 7 8 . The military population has also been exposed to OP chemicals. Approximately 30% of returning soldiers from the Persian Gulf War suffer from a cluster of symptoms commonly known as Gulf War Syndrome. Prolonged exposure to OP based pesticides or exposure to Sarin gas, following demolition of chemical weapon stockpiles are amongst the possible causes thought to be responsible for this syndrome [9] [10] [11] . The ease of availability of pesticides make them attractive target to be weaponized and cause mass civilian causalities. Thus, there is a growing threat of OP toxicity in the current geopolitical environment.
Research in this field has provided therapeutic antidotes that are critical in limiting immediate mortality associated with lethal OP intoxication 12 . However, further research is needed to identify molecular mechanisms underlying chronic mortality and morbidity in order to develop effective counteract therapeutics following OP exposure 13 .
Organophosphate Poisoning: Mechanisms, Treatments, and Challenges Paraoxon (POX) is an active metabolite of parathion and is used in laboratory research to reliably model OP pesticide toxicity 14 . Similarly, diisopropyl fluorophosphates (DFP) is used in civilian research as a nerve agent surrogate to model sarin exposure given the ease of handling associated with DFP [15] [16] [17] [18] . POX, DFP and other OP chemicals are potent inhibitors of the enzyme acetylcholinesterase (AChE) 19 . Inhibition of AChE prevents breakdown of the neurotransmitter acetylcholine (ACh) and rapidly builds up ACh level at the synapses. Overstimulation of ACh receptors leads to the classical "cholinergic crisis" characterized by salivation, lacrimation, urination, and defecation. This is followed by respiratory depression and bradycardia. Nicotinic receptor stimulation causes muscle fasciculation. This is followed by tonic-clonic seizures and status epilepticus (SE), or prolonged seizure activity that continues unabated and results in the . While the current antidotes are critical in limiting immediate mortality associated with OP exposure, OP/ SE survivors are vulnerable to delayed mortality in the critical 2-week period post initial survival and the development of chronic neurological morbidities such as recurrent seizures, depression and cognitive deficits 14, 22, [27] [28] [29] [30] [31] [32] [33] [34] [35] . Thus, it is essential to develop valid animal models that mimic OP mortality and morbidity and to identify molecular mechanisms underlying long-term neurological deficits from survival of OP toxicity in order to develop effective counteract therapeutics.
Rat survival models of OP-SE
Many OP studies in literature have focused on effects of low-dose, chronic OP exposure or effects of OP's following in-utero exposure [36] [37] [38] [39] . There are also studies reporting models of acute parathion 40, 41 and POX exposures [42] [43] [44] . However, these models did not focus on evaluating long term survival after lethal POX SE exposures. Development of OP SE models is also complicated by their variable pharmacokinetic and pharmacodynamics response, such as the challenges associated with parathion kinetics and differential metabolism [45] [46] [47] . We wanted to further develop a reliable rat survival model for lethal OP exposure with SE that would replicate both the acute mortality and chronic morbidity associated with these agents. Such animal models could be very useful to study molecular mechanisms of OP toxicities and screen medical countermeasures to improve survival following OP exposures.
To this end we have developed two SE survival models of OP toxicity using lethal doses of POX 14 and DFP 16 . The behavioral manifestations, and EEG profile for these OP SE models mimicked the signs and symptoms of acute OP intoxication. In this model, rats were exposed to a lethal dose (approximately 2x LD50) of OP chemical (POX or DFP) and were treated with FDA approved drugs to limit immediate mortality 26 . Here we will discuss the POX model of OP-SE.
One week prior to SE experiments, rats were stereotaxically implanted with skull surface electrodes to record EEG. Briefly, one minute following POX injection (2 mg/kg, s.c.) animals received human-dose equivalents of 2-PAM (25 mg/kg, i.m.) and atropine (0.5 mg/kg, i.m.). imaging or behavioral experiments. Chronic mortality (72-h and beyond) in these models of severe OP intoxication was 18-20% 14, 16 . These POX and DFP SE survival models manifested the same degree of delayed mortality and morbidity (see below) observed in the human OP exposure condition [49] [50] [51] [52] [53] .
Development of "Ca
2+ Plateau" following survival from OP-SE dynamics following OP toxicity could therefore underlie the associated neuronal injury and together they be responsible for the chronic neurological morbidities following OP SE 14 survival (Fig. 4) .
Neuronal Injury following OP-SE
Neuronal loss in several brain regions has been observed following SE 54, 55 , OP SE 14, 15 and other chemical threat agents 61 . We have observed widespread neuronal loss induced by POX SE.as assessed using the Fluoro Jade (FJC) labeling technique 14, 62 . FJC-positive staining neurons were observed within the hippocampus, parietal cortex, and in both amygdala and thalamic nuclear regions of POX SE rats (Fig. 2) . Damages to these critical brain areas have been implicated in memory impairment, depression, anxiety, epilepsy and other neurological morbidities 27, 63, 64 .
Chronic morbidity following survival from OP-SE
We have also analyzed OP SE survivors in these animal models for the development of neurological morbidities (Fig. 3) . We have observed symptoms of chronic depression and memory impairments in these OP exposed rats 62, 65 . 62, 65 . Together, despair, anhedonia, and anxiety constituted symptoms of depression. In addition, these rats performed poorly in the Novel Object
Recognition task indicative of memory impairment 62, 65 . Survival from OP SE was also associated with significant neuronal damage throughout the limbic system, particularly the hippocampus 14, 16 . plateau could make them attractive neuroprotective adjuvant treatments following OP-SE. These agents could also prove beneficial in reducing the chronic neurological morbidities observed in OP SE survivors. We are actively exploring these possibilities in our laboratories (Fig. 4) .
Despite advances in developing more effective agents for controlling the cholinergic crisis associated with OP SE, there is a pressing need to develop counteract treatments that prevent or reduce the high mortality and the chronic morbidity associated with OP SE. This is an important area of research that has direct translational implications for clinical treatment 74, 75 .
Development of animal models of OP SE are critical to identifying molecular mechanisms underlying symptoms of OP toxicity. This knowledge can provide molecular targets that can be used to develop effective therapies for the treatment of OP SE (Fig. 4) 
